- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/15 - Oximes (C=N—O—)Hydrazines (N—N)Hydrazones (N—N=)
Patent holdings for IPC class A61K 31/15
Total number of patents in this class: 671
10-year publication summary
34
|
41
|
56
|
42
|
49
|
70
|
66
|
47
|
38
|
21
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Antecip Bioventures II LLC | 340 |
56 |
Clexio Biosciences Ltd. | 104 |
20 |
Vanda Pharmaceuticals, Inc. | 367 |
17 |
Oklahoma Medical Research Foundation | 157 |
12 |
The Regents of the University of California | 20153 |
10 |
Hough Ear Institute | 29 |
10 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2925 |
7 |
The Trustees of the University of Pennsylvania | 4366 |
6 |
Kyushu University, National University Corporation | 1661 |
6 |
Bristol-myers Squibb Company | 4840 |
5 |
Centre National de La Recherche Scientifique | 10595 |
5 |
Dow Global Technologies LLC | 10459 |
5 |
Duke University | 3092 |
5 |
Dana-Farber Cancer Institute, Inc. | 2602 |
5 |
Emory University | 1643 |
5 |
Enanta Pharmaceuticals, Inc. | 432 |
5 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3369 |
5 |
Institut Gustave Roussy | 263 |
5 |
Nippon Chemiphar Co., Ltd. | 232 |
5 |
Université Paris-saclay | 555 |
5 |
Other owners | 472 |